| Literature DB >> 26095253 |
Si Ming Man1, Qifan Zhu2, Liqin Zhu3, Zhiping Liu4, Rajendra Karki1, Ankit Malik1, Deepika Sharma1, Liyuan Li3, R K Subbarao Malireddi1, Prajwal Gurung1, Geoffrey Neale5, Scott R Olsen5, Robert A Carter6, Daniel J McGoldrick6, Gang Wu6, David Finkelstein6, Peter Vogel7, Richard J Gilbertson8, Thirumala-Devi Kanneganti9.
Abstract
Colorectal cancer is a leading cause of cancer-related deaths. Mutations in the innate immune sensor AIM2 are frequently identified in patients with colorectal cancer, but how AIM2 modulates colonic tumorigenesis is unknown. Here, we found that Aim2-deficient mice were hypersusceptible to colonic tumor development. Production of inflammasome-associated cytokines and other inflammatory mediators was largely intact in Aim2-deficient mice; however, intestinal stem cells were prone to uncontrolled proliferation. Aberrant Wnt signaling expanded a population of tumor-initiating stem cells in the absence of AIM2. Susceptibility of Aim2-deficient mice to colorectal tumorigenesis was enhanced by a dysbiotic gut microbiota, which was reduced by reciprocal exchange of gut microbiota with healthy wild-type mice. These findings uncover a synergy between a specific host genetic factor and gut microbiota in determining the susceptibility to colorectal cancer. Therapeutic modulation of AIM2 expression and microbiota has the potential to prevent colorectal cancer.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26095253 PMCID: PMC4491002 DOI: 10.1016/j.cell.2015.06.001
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582